Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.22.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 2 $ 129,725 $ (72,258) $ 57,469
Balance (in Shares) at Dec. 31, 2020 23,264,637      
Exercise of stock options [1] 23 23
Exercise of stock options (in Shares) 12,646      
Exercise of warrant [1]  
Exercise of warrant (in Shares) 362,383      
Issuance of Common Stock under Open Market Sales Agreement [1] 4,334 4,334
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 601,674      
Stock-based compensation expenses 530 530
Net loss (8,402) (8,402)
Balance at Mar. 31, 2021 $ 2 134,612 (80,660) 53,954
Balance (in Shares) at Mar. 31, 2021 24,241,340      
Balance at Dec. 31, 2020 $ 2 129,725 (72,258) 57,469
Balance (in Shares) at Dec. 31, 2020 23,264,637      
Net loss       (15,738)
Balance at Jun. 30, 2021 $ 2 136,586 (87,996) 48,592
Balance (in Shares) at Jun. 30, 2021 24,429,076      
Balance at Mar. 31, 2021 $ 2 134,612 (80,660) 53,954
Balance (in Shares) at Mar. 31, 2021 24,241,340      
Exercise of stock options [1] 78 78
Exercise of stock options (in Shares) 55,246      
Issuance of Common Stock under Open Market Sales Agreement [1] 801 801
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 132,490      
Stock-based compensation expenses 1,095 1,095
Net loss (7,336) (7,336)
Balance at Jun. 30, 2021 $ 2 136,586 (87,996) 48,592
Balance (in Shares) at Jun. 30, 2021 24,429,076      
Balance at Dec. 31, 2021 $ 2 156,017 (108,484) 47,535
Balance (in Shares) at Dec. 31, 2021 29,747,538      
Issuance of Common Stock under Open Market Sales Agreement [1],[2] 37 37
Issuance of Common Stock under Open Market Sales Agreement (in Shares) [1],[2] 27,171      
Stock-based compensation expenses 615 615
Net loss (8,169) (8,169)
Balance at Mar. 31, 2022 $ 2 156,669 (116,653) 40,018
Balance (in Shares) at Mar. 31, 2022 29,774,709      
Balance at Dec. 31, 2021 $ 2 156,017 (108,484) $ 47,535
Balance (in Shares) at Dec. 31, 2021 29,747,538      
Exercise of stock options (in Shares)      
Net loss       $ (15,651)
Balance at Jun. 30, 2022 $ 2 156,872 (124,135) 32,739
Balance (in Shares) at Jun. 30, 2022 29,774,709      
Balance at Mar. 31, 2022 $ 2 156,669 (116,653) 40,018
Balance (in Shares) at Mar. 31, 2022 29,774,709      
Stock-based compensation expenses 184 184
Proceeds on account of shares   19   19
Net loss (7,482) (7,482)
Balance at Jun. 30, 2022 $ 2 $ 156,872 $ (124,135) $ 32,739
Balance (in Shares) at Jun. 30, 2022 29,774,709      
[1] Less than $1.
[2] See Note 5A.